7T Healthy Ageing Study

OnabotulinumtoxinA treatment for MS-tremor modifies fMRI tremor response in central sensory-motor integration areas

FMC Boonstra, A Evans, G Noffs, T Perera, V Jokubaitis, J Stankovich, AP Vogel, BA Moffat, H Butzkueven, SC Kolbe, A van der Walt

2020-05-01

Background: Treatment of tremor in MS is an unmet need. OnabotulinumtoxinA (BoNT-A) has shown promising results; however, little i..